GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (LTS:0IL8) » Definitions » Policy Acquisition Expense

FibroGen (LTS:0IL8) Policy Acquisition Expense


View and export this data going back to 2018. Start your Free Trial

What is FibroGen Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


FibroGen (LTS:0IL8) Business Description

Industry
Traded in Other Exchanges
Address
409 Illinois Street, San Francisco, CA, USA, 94158
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.